Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
| Price | $0.48 |
|---|---|
| Market cap | $8.06M |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| Exchange | NASDAQ |
| 52-week range | 0.162-2.75 |
| Beta | 2.05 |
Explore MGRX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.